U.S. Physical Therapy Inc. (USPH) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for U.S. Physical Therapy Inc. (USPH:NYSE), powered by AI.

Current Price
$66.39
P/E Ratio
66.9
Market Cap
1.0B
Sector
Healthcare
What is the U.S. Physical Therapy Inc. stock price forecast?

U.S. Physical Therapy Inc. is currently trading at $66.39. View real-time AI analysis on Alpha Lenz.

What is U.S. Physical Therapy Inc. insider trading activity?

View the latest insider trading data for U.S. Physical Therapy Inc. on Alpha Lenz.

What is U.S. Physical Therapy Inc.'s P/E ratio?

U.S. Physical Therapy Inc.'s P/E ratio is 66.9.

U.S. Physical Therapy Inc.

NYSE · USPH
$66.39+0.87(+1.33%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about U.S. Physical Therapy Inc.'s future dividend policy...
Alpha Chat Insight

U.S. Physical Therapy Inc. trades at a P/E of 66.9 (premium valuation) with modest ROE of 3.1%. 3Y revenue CAGR of 12.2% highlights clear growth momentum.

Ask for details

Company Overview

U.S. Physical Therapy Inc. is a leading operator of outpatient physical therapy clinics in the United States. The primary function of this company is to provide rehabilitation services to individuals recovering from various physical ailments, such as orthopedic issues, sports injuries, and postoperative conditions. The company operates a network of strategically located clinics, emphasizing patient-centered care and evidence-based treatment practices. U.S. Physical Therapy Inc. engages in partnerships with hospitals, physicians, and employers to deliver comprehensive therapy solutions tailored to the specific needs of the population served. In an industry focused on healthcare and wellness, U.S. Physical Therapy plays a critical role by improving patient mobility, reducing pain, and enhancing overall quality of life. This company is integral to the healthcare sector, contributing to the growing demand for physical therapy services driven by an aging population and increased awareness of the benefits of rehabilitation therapy. Headquartered in Houston, Texas, U.S. Physical Therapy Inc. exemplifies the intersection of healthcare service innovation and expanding care accessibility.

CEOMr. Christopher J. Reading
SectorHealthcare
IndustryMedical Care Facilities
Employees4,034

Company Statistics

FY 2025

Profile

$1.01BMarket Cap
$780.99MRevenue
0.00Shares Out
4,034Employees

Margins

19.17%Gross
13.43%EBITDA
10.30%Operating
9.96%Pre-Tax
7.43%Net

Valuation

66.89P/E
2.11P/B
1.29EV/Sales
15.08EV/EBITDA
16.52P/FCF

Growth (CAGR)

12.19%Rev 3Yr
13.05%Rev 5Yr
6.86%Op Inc 3Yr
4.06%Op Inc 5Yr
10.15%Net Inc 3Yr
2.02%Net Inc 5Yr

Returns

4.89%ROA
3.12%ROE
7.36%ROIC

Financial Health

$35.57MCash & Cash Equivalents
$398.24MNet Debt
56.32%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

U.S. Physical Therapy Inc. (ticker: USPH) is a company listed on NYSE in the Healthcare sector (Medical Care Facilities). It has approximately 4,034 employees. Market cap is $1.0B.

The current price is $66.39 with a P/E ratio of 66.89x and P/B of 2.11x.

ROE is 3.12% and operating margin is 10.30%. Annual revenue is $781M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
U.S. Physical Therapy Inc. (USPH) Stock Forecast 2026 $66.39 — Price, Financials & Analyst Targets | Alpha Lenz